Literature DB >> 11386459

Influence of thoracic radiotherapy on exhaled nitric oxide levels in patients with lung cancer.

M Koizumi1, H Yamazaki, K Toyokawa, Y Yoshioka, G Suzuki, M Ito, K Shinkawa, K Nishino, Y Watanabe, T Inoue, S Ozeki, S Matsumura, T Inoue.   

Abstract

BACKGROUND: To determine the physiological role of exhaled nitric oxide (NO) in patients with lung cancer.
METHODS: We investigated changes in exhaled NO levels in 29 patients undergoing thoracic radiation therapy with or without chemotherapy. The exhaled NO level was assessed using a chemiluminescence analyzer.
RESULTS: The level of exhaled NO was higher in patients with lung cancer before treatment than in controls. With radiotherapy, the exhaled NO level decreased for patients undergoing 40 Gy irradiation and post-radiotherapy. However, five patients showed elevated levels of exhaled NO three times or more than that before radiotherapy. Three of these patients showed signs of radiation pneumonitis. However, none of the other patients showed signs of radiation pneumonitis (p = 0.002).
CONCLUSION: Radiation therapy can lower exhaled levels of NO and the levels of exhaled NO may be a useful index for the early prediction of radiation pneumonitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386459     DOI: 10.1093/jjco/hye028

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Elevation in exhaled nitric oxide predicts for radiation pneumonitis.

Authors:  Thomas Guerrero; Josue Martinez; Matthew R McCurdy; Michael Wolski; Mary Francis McAleer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

Review 2.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

3.  Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy.

Authors:  Hideya Yamazaki; Norihiro Aibe; Satoaki Nakamura; Naomi Sasaki; Gen Suzuki; Ken Yoshida; Kei Yamada; Masahiko Koizumi; Taichiro Arimoto; Yoshinobu Iwasaki; Yoshiko Kaneko; Koichi Takayama
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

4.  Nitric oxide in occurrence, progress and therapy of lung Cancer: a systemic review and meta-analysis.

Authors:  Hongbin Zhou; Jiuke Li; Zhewen Chen; Ying Chen; Sa Ye
Journal:  BMC Cancer       Date:  2021-06-08       Impact factor: 4.430

5.  Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients?

Authors:  Irina Enache; Georges Noel; M Young Jeung; Nicolas Meyer; Monique Oswald-Mammosser; Emile Urban-Kraemer; Catherine Schumacher; Bernard Geny; Elisabeth Quoix; Anne Charloux
Journal:  Radiat Oncol       Date:  2012-07-28       Impact factor: 3.481

6.  Acetaldehyde and hexanaldehyde from cultured white cells.

Authors:  Hye-Won Shin; Brandon J Umber; Simone Meinardi; Szu-Yun Leu; Frank Zaldivar; Donald R Blake; Dan M Cooper
Journal:  J Transl Med       Date:  2009-04-29       Impact factor: 5.531

7.  Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer.

Authors:  Nicole L K Pershing; Chi-Fu Jeffrey Yang; MengMeng Xu; Christopher M Counter
Journal:  Oncotarget       Date:  2016-07-05

8.  Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study.

Authors:  W M Szejniuk; M S Nielsen; D Brønnum; Z Takács-Szabó; U M Weinreich; L Pilegaard Thomsen; M Bøgsted; I Jensen; T McCulloch; U G Falkmer; J Carl; O D Røe
Journal:  Clin Transl Radiat Oncol       Date:  2019-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.